Loading clinical trials...
Loading clinical trials...
Preventive and Therapeutic Effects of Oral 25-hydroxyvitamin D3 on Coronavirus (COVID-19) in Adults
Conditions
Interventions
Oral 25-Hydroxyvitamin D3
Locations
1
Iran
Tehran University of Medical Sciences
Tehran, Iran
Start Date
April 14, 2020
Primary Completion Date
November 15, 2020
Completion Date
March 15, 2021
Last Updated
June 12, 2020
NCT07278388
NCT07123727
NCT07013903
NCT05040659
NCT06391489
NCT06992401
Lead Sponsor
Tehran University of Medical Sciences
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions